Skip to main content

Read our report on six communities’ experiences with pandemic funding and programs, which provides valuable lessons learned to improve federal emergency response programs.

X
Skip to list of reports Filters

Date Range

Reports

Search reports, investigative results, and agency plansShowing 1 - 10 of 53 results
Department of Defense OIG

Audit of DoD Use of the Government Purchase Card in Response to the Coronavirus Disease–2019 Pandemic

The objective of this audit is to determine whether cardholders used the Government Purchase Card to support DoD's response to the pandemic in accordance with Federal and DoD policies. We may revise the objective as the audit proceeds, and we will also consider suggestions from management for additional or revised objectives.

Department of Defense OIG

Audit of Military Departments’ Processing of Coronavirus Disease–2019 Vaccination Exemptions and Disciplinary Actions for Active Duty Service Member

The objective of this audit is to determine whether the Military Departments are processing exemption requests for the Coronavirus Disease–2019 vaccination and taking disciplinary actions for active duty Service members in accordance with Federal and DoD guidance. 

Department of Defense OIG

Audit of DoD Actions Taken to Implement Cybersecurity Protections Over Remote Access Software in the Coronavirus Disease–2019 Telework Environment

We are conducting the subject audit at the request of the House Committee on Oversight and Reform. The objective of this audit is to determine the actions taken by the DoD to configure remote access software used to facilitate telework during the COVID-19 pandemic to protect DoD networks and systems from potential malicious activity. We will also determine the extent to which the DoD implemented security controls to protect remote connections to its networks. We may revise the objective as the audit proceeds, and we will consider suggestions from management for additional or revised objectives.

Department of Defense OIG

Audit of DoD Actions Taken to Protect DoD Information When Using Collaboration Tools During the COVID-19 Pandemic

The objective of this audit is to determine whether DoD’s deployment of collaboration tools used to facilitate telework during the coronavirus disease–2019 (COVID-19) pandemic exposed DoD networks and systems to potential malicious activity, and the extent to which the DoD implemented security controls to protect the collaboration tools used on its networks. We will perform this audit in accordance with generally accepted government auditing standards. We may revise the objective as the audit proceeds, and we will consider suggestions from DoD management for additional or revised objectives.

Small Business Administration OIG

Evaluation of SBA’s Awards to Highlight Technologies LLC to Meet Emerging Needs Related to COVID-19

The Office of Inspector General will conduct an evaluation of SBA’s awards made to Highlight Technologies LLC to meet emerging needs related to impacts of COVID-19. Our project is part of a series of reviews of contracts SBA awarded to support CARES Act and other COVID-19 related legislation programs. Our objective is to determine if SBA issued the blanket purchase agreement and contract modifications in accordance with federal laws, regulations, and internal guidance.

Small Business Administration OIG

Small Business Administration’s Implementation of the Restaurant Revitalization Fund

The Office of Inspector General Audits Division will perform an evaluation of the Small Business Administration’s implementation of the Restaurant Revitalization Fund. Our objectives are to determine if SBA designed the program to (1) align with the American Rescue Plan Act requirements including whether designated groups were prioritized and (2) minimize the risk of financial loss.

Department of Health & Human Services OIG

Audit of Health Resources and Services Administration's COVID-19 Supplemental Grant Funding for Health Centers

The Health Resources and Services Administration (HRSA) awarded nearly $2 billion in supplemental grant funding to 1,387 health centers nationwide in fiscal year (FY) 2020 to respond to the COVID-19 public health emergency. The funding was intended to support the health centers' activities related to the detection, prevention, diagnosis, and treatment of COVID-19, including maintaining or increasing health center capacity and staffing levels during the pandemic, and expanding COVID-19 testing. The performance period for each of these one-time supplemental grant awards, which HRSA began awarding in March 2020, is 12 months. Health centers were permitted to charge to their awards pre-award costs in order to support expenses related to the COVID-19 public health emergency dating back to January 20, 2020. We will determine whether health centers used their HRSA COVID-19 supplemental grant funding in accordance with Federal requirements and grant terms.

Small Business Administration OIG

SBA’s Handling of Potentially Fraudulent Paycheck Protection Program Loans

Inspection Notification: SBA’s Handling of Potentially Fraudulent Paycheck Protection Program Loans

Department of Health & Human Services OIG

Yearend Review of Opioid Use in Medicare Part D in 2020

Identifying patients who are at-risk of overdose or abuse is key to addressing this crisis. The COVID-19 pandemic has made this need even more pressing. The National Institutes of Health recently warned that individuals with opioiduse disorder could be particularly hard hit by COVID-19, which is a respiratory virus that attacks the lungs. Respiratory disease is known to increase mortality risks among people taking opioids. This data brief would provide information on opioid utilization among beneficiaries enrolled in Medicare Part D in 2020. 

Department of Health & Human Services OIG

Awardee Challenges in Implementing COVID_19 Vaccination Program

CDC Immunization and Vaccines for Children Cooperative Agreement awardees, which are typically State and large metropolitan area public health departments, plan for and oversee the vaccine distribution and administration process. Stakeholders have acknowledged challenges early in Phase 1 distribution and dispensing, and note that these challenges will likely span all three phases identified in the CDC's COVID-19 Vaccine Playbook. We will interview all awardees to identify the reported challenges they are facing while distributing and dispensing vaccines. We will also ask awardees about effective strategies to mitigate those challenges, new challenges they anticipate, and how HHS can best support them in distributing and dispensing COVID-19 vaccines. In doing so, this review will provide HHS with timely and actionable information to address challenges associated with the COVID-19 vaccination efforts.